japan

Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawal

Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawal

Takeda Pharmaceutical Co Ltd (4502.T) said on Monday it anticipates an operating loss of about $200 million related to Novartis AG’s